Skip to main navigation Skip to search Skip to main content

A Mutlicenter, Randomized, Double-Blind, Placebo-Controlled Trial os Emricasan (IDN-6556), an Oral Caspase Inhibitor, in Subjects with Non-alcoholic Steatohepatitis (NASH) Fibrosis

Project: Research

Project Details

StatusFinished
Effective start/end date12/7/16 → 12/6/20

Funding

  • Conatus Pharmaceuticals Incorporated: $17,595.00